Sudhir Srivastava

Papers

Total Citations

H-Index

About

Dr. Sudhir Srivastava has dedicated his career to advancing noninvasive cancer diagnostics, with a central focus on telomerase—an enzyme expressed in 85–90% of all human cancers but absent in normal somatic tissues. His pioneering work targets the analytical validation and standardization of telomerase activity assays for early cancer detection, a field where he has made foundational contributions. In his landmark 2004 paper, "Analytical Validation of Telomerase Activity for Cancer Early Detection" (30 citations), he established critical benchmarks for assay reliability. He further advanced the field by developing high-throughput detection methods using capillary electrophoresis (2003, 23 citations) and by spearheading the creation of candidate reference materials for telomerase assays (2005, 18 citations), addressing the pressing need for reproducible, cost-effective clinical tests. These efforts aim to enable noninvasive screening from easily obtained body fluids, potentially transforming cancer diagnostics. Dr. Srivastava’s work on assay standardization and high-throughput analysis has laid essential groundwork for translating telomerase detection from research labs into practical, early-cancer screening tools, underscoring his lasting impact on molecular diagnostics.